— Know what they know.
Not Investment Advice

HLVX NASDAQ

HilleVax, Inc.
1W: +0.0% 1M: +1.5% 3M: +11.2% 1Y: +16.8% 3Y: -90.5%
$2.09
Last traded 2025-09-18 — delisted
NASDAQ · Healthcare · Biotechnology · $104.8M mcap · 23M float · 3.16% daily turnover · Short 47% of daily vol

📊 Key Metrics

TTM
$0M
Revenue
-100.0% YoY
$-71M
Net Income
+54.5% YoY
$-61M
Free Cash Flow
+52.1% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-40.3%
ROA-31.5%
ROIC-515.7%

Valuation

P/E-0.7
P/B0.7
EV/EBITDA0.5

Leverage

Debt/Equity0.16
Current Ratio26.39
Interest Cov.-37.4x

Quality Scores

Piotroski F4/9
Altman Z-2.41
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms